Reversal of apixaban and rivaroxaban anticoagulation by andexanet alfa in ANNEXA-A&R as assessed by non-tissue factor (TF)-initiated thrombin generation independent of TF pathway inhibitor (TFPI)
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- August 1, 2018
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Cardiovascular System & Hematology (Science Metrix)
published in
- European Heart Journal Journal
presented at event
- European-Society-of-Cardiology Congress Conference